Sonodynamic Therapy in Periodontitis: From Mechanisms to Biomaterial-Based Innovations
- 1State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Chengdu, Sichuan, People’s Republic of China
- 2Department of Dental Medical Center, China-Japan Friendship Hospital, Beijing, People’s Republic of China
Abstract
Periodontitis is a common chronic inflammatory disease driven by pathogenic biofilms, leading to progressive periodontal tissue destruction and systemic health risks. Conventional therapies often fail to eradicate biofilms in deep periodontal pockets, promote antimicrobial resistance and offer limited regenerative potential. Although SDT has emerged as a promising alternative, its clinical efficacy is constrained by several material- and microenvironment-related barriers that have not been systematically addressed in previous reviews. Sonodynamic therapy (SDT) employs low-intensity ultrasound to activate sonosensitizers, generating reactive oxygen species (ROS) and inducing mechanical disruption of biofilms, with advantages of deep tissue penetration, broad-spectrum antimicrobial activity and low risk of resistance. Nevertheless, conventional sonosensitizers often exhibit poor water solubility, rapid clearance, limited specificity, and suboptimal ROS generation, while hypoxia, continuous fluid turnover, and mechanical disturbance within periodontal pockets further compromise local retention and therapeutic efficacy. Advances in biomaterials address these barriers by engineering high-performance sonosensitizers to enhance ROS efficiency, developing delivery systems to improve solubility and prolonged retention and integrating multimodal antibacterial and regenerative functions. This review summarizes the mechanistic basis of SDT with recent advances in sonosensitizer engineering, local delivery platforms, synergistic therapies, and multifunctional biomaterials, thereby linking antimicrobial performance to periodontal tissue regeneration. We further identify hypoxia, delivery efficiency, biosafety and the lack of standardized evaluation as key translational challenges, and propose future directions including AI-guided sonosensitizer design, precision delivery systems, and CRISPR-assisted antimicrobial combination strategies to accelerate the clinical translation of SDT for periodontitis management.
Related
- CAR T-Cell Therapy in Hematological Malignancies: Mechanisms, Innovations, and Challenges
- A self-sufficient nanoreactor orchestrating calcium overload and sonodynamic/chemodynamic-amplified ferroptosis for oral squamous cell carcinoma therapy.
- Acid-responsive nanoparticles with microneedles for anti‑inflammatory sonodynamic therapy of gouty arthritis.
- Advanced cell-laden hydrogels for diabetic wound healing: Biomaterial design, therapeutic mechanisms, and translational challenges
- Bidirectional Interplay Between Periodontitis and Alzheimer’s Disease: Mechanisms, Clinical Management, and Preventive Strategies
BibTeX
@article{li2026sonodynamic,
title = {{Sonodynamic Therapy in Periodontitis: From Mechanisms to Biomaterial-Based Innovations}},
author = {Yijun Li and Xin Xiong and Ziang Xu and Xinnan Zhong and Jingchen Xu},
journal = {International Journal of Nanomedicine},
year = {2026},
month = oct,
doi = {10.2147/ijn.s642010},
url = {https://doi.org/10.2147/ijn.s642010},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Sonodynamic Therapy in Periodontitis: From Mechanisms to Biomaterial-Based Innovations
AU - Yijun Li
AU - Xin Xiong
AU - Ziang Xu
AU - Xinnan Zhong
AU - Jingchen Xu
PY - 2026
DA - 2026/10/27
JO - International Journal of Nanomedicine
DO - 10.2147/ijn.s642010
UR - https://doi.org/10.2147/ijn.s642010
AB - Periodontitis is a common chronic inflammatory disease driven by pathogenic biofilms, leading to progressive periodontal tissue destruction and systemic health risks. Conventional therapies often fail to eradicate biofilms in deep periodontal pockets, promote antimicrobial resistance and offer limited regenerative potential. Although SDT has emerged as a promising alternative, its clinical efficacy is constrained by several material- and microenvironment-related barriers that have not been systematically addressed in previous reviews. Sonodynamic therapy (SDT) employs low-intensity ultrasound to activate sonosensitizers, generating reactive oxygen species (ROS) and inducing mechanical disruption of biofilms, with advantages of deep tissue penetration, broad-spectrum antimicrobial activity and low risk of resistance. Nevertheless, conventional sonosensitizers often exhibit poor water solubility, rapid clearance, limited specificity, and suboptimal ROS generation, while hypoxia, continuous fluid turnover, and mechanical disturbance within periodontal pockets further compromise local retention and therapeutic efficacy. Advances in biomaterials address these barriers by engineering high-performance sonosensitizers to enhance ROS efficiency, developing delivery systems to improve solubility and prolonged retention and integrating multimodal antibacterial and regenerative functions. This review summarizes the mechanistic basis of SDT with recent advances in sonosensitizer engineering, local delivery platforms, synergistic therapies, and multifunctional biomaterials, thereby linking antimicrobial performance to periodontal tissue regeneration. We further identify hypoxia, delivery efficiency, biosafety and the lack of standardized evaluation as key translational challenges, and propose future directions including AI-guided sonosensitizer design, precision delivery systems, and CRISPR-assisted antimicrobial combination strategies to accelerate the clinical translation of SDT for periodontitis management.
SN - 1176-9114
SN - 1178-2013
ER -